1887

Chapter 20 : Preventive Strategies for Intravascular Catheter-Related Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Preventive Strategies for Intravascular Catheter-Related Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818067/9781555811778_Chap20-1.gif /docserver/preview/fulltext/10.1128/9781555818067/9781555811778_Chap20-2.gif

Abstract:

Millions of intravascular catheters are purchased each year by hospitals and clinics, placing many patients at risk for serious catheter-related infections. This chapter summarizes the rapidly expanding body of literature concerning prevention of intravascular catheter-related infections in the hope of reducing the risk posed to present and future patients. Prophylaxis with vancomycin or teicoplanin during central venous catheter insertion does not reduce the incidence of catheter-related bloodstream infection. The addition of prophylactic vancomycin to flush solutions or total parenteral nutrition solutions significantly reduces the incidence of catheter-related bloodstream infection; however, use of systemic antimicrobial agents to prevent intravascular catheter-related infections is not recommended. Administering very low doses of warfarin reduces thrombosis due to long-term central venous catheters. Use of prophylactic heparin by bolus infusion or when it is added to intravenous solutions does not significantly reduce the risk of central venous catheter-related bloodstream infection. Prophylactic heparin significantly reduces the incidence of catheter-related central venous thrombosis in patients with central venous and pulmonary artery catheters. A number of different strategies can be used to prevent serious intravascular catheter-related infections.

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20

Key Concept Ranking

Catheter-Related Bloodstream Infections
0.74484825
0.74484825
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

The I System hub designed to prevent catheter-related bloodstream infection.

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

The Segur Lock hub designed to prevent catheter-related bloodstream infection.

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818067.chap20
1.Anonymous. 1997. Interim guidelines for prevention and control of staphylococcal infections associated with reduced susceptibility to vancomycin. Morb. Murtal. Wkly. Rep. 46:626628, 635.
2.Anonymous. 1998. National nosocomial infections surveillance (NNIS) system report, data summary from October 1986-April 1998. issued June 1998. Am. J. Infect. Control 26:522533.
3.Anonymous. 1994. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC). Morb. Mortal. Wkly. Rep. 44:113.
4. Appelgren, P.,, U. Rans jo,, L. Bindslcv,, F. Espersen,, and O. Larm. 1996. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit. Care Med. 24:14821489.
5. Arepally, G.,, and D. B. Cines. 1998. Hepann-induced thrombocytopenia and thrombosis. Clin. Rev. Allergy Immunol. 16:237247.
6. Armstrong, P.,, N. Allien,, M. Clowser,, R. A. Steinberg,, M. E. Spornitz,, W. Runge, et al. 1998. Central line-associated (CLA) surveillance and continuing quality improvement in an intensive care unit (1CU). J. Hosp. Infect. 40(Suppl. A):8.1.8..
7. Arnow, P. M.,, E. M. Quimosing,, and M. Beach. 1993. Consequences of intravascular catheter sepsis. Clin. Infect. Dis. 16:778784.
8. Bach, A.,, H. Eberhardt,, A. Frick,, H. Schmidt,, B. W. Bottiger,, and E. Martin. 1999. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit. Care Med. 27:515521.
9. Bach, A.,, H. Schmidt,, B. Bottiger,, B. Schricber,, H. Bolirer,, J. Motsch, et al. 1996. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J. Antimicrob. Chemother. 37:315322.
10. Bern, M. M.,, J. J. Lokich,, S. R. Wallach,, A. Bothe,, P. N. Benotti,, C. F. Arkin, et al. 1990. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann. Intern. Med. 112:423428.
11. Bonawitz, S. C.,, J. J. Hammell,, and J. R. Kirkpatrick. 1991. Prevention of central venous catheter sepsis: a prospective randomized trial. Amn. Surg. 57:618623.
12. Borkas, P.,, J. Seale,, G. Bass,, M. Ethell,, D. Keeling,, P. Mahendra, et al. 1998. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haemotological malignancies. Br. J. Haematol. 101:483486.
13. Boswald, M.,, S. Lugauer,, A. Regenfus,, G. G. Braun,, P. Martus,, C. Geis. et al. 1999. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 27(Suppl. I ):S56S60.
14. Brennan, P. J.,, C. Hoegg,, C. Samel,, D. Skalina,. S. Barbagallo,, and D. Shulkkn. 1997 Performance improvement in a medical intensive care unit (MICU) resulting from device based surveillance (DSB) from central venous catheter related bloodstream infections (CVC-BSI). Infect. Control Hasp. Epidemiol. 18(5. part 2):20.
15. Byers, K.,, K. Adal,, A. Anglim,, and B. Farr. 1995. Case fatality rate for catheter-related bloodstream infections (CRBS1): a meta-analysis. Infect. Control Hosp. Epidemiol. 16(Part 2 Suppl.):23.
16. Chang, F. Y.,, N. Singh,, T. Gayowski,, M. M. VVagener,, and I. R. Marino. 1998. Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infect. Control Hosp. Epidemiol. 19:328332.
17. Clemence, M. A.,, D. Walker,, and B. M. Farr. 1995. Central venous catheter practices: results of a survey. Am. J. infect. Control 23:512.
18. Cohen, Y.,, J. P. Fosse,, P. Daroubi,, J. Reboul-Marty. D. Dreyfuss, P. Hoang, et al. 1998. The liands-off" catheter and the prevention of systemic infections associated with pulmonary artery cathteter. A prospective study. Am. J. Hespir. Crit. Care Med. 157:284287.
19. Collignon, P. J. 1994. Intravascular catheter associated sepsis: a common problem. Med. J. Aitsl. 161: 374378.
20. Collin, G. R. 1999. Decreased catheter colonization through the use of an antiseptic-impregnated catheter. A continuous quality improvement project. Chest 115:16321640.
21. Conly, J. M.,, K. Grieves,, and B. Peters. 1989. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J. Infect. Dis. 159:310319.
22. Cook, D.,, A. Randoph,, P. Kernerman,, C. Cupido,, D. King,, C. Soukup, et al. 1997. Central venous catheter replacement strategies: a systematic review of the literature. Crit. Care Med. 25:14171424.
23. Dahlberg, P. J.,, W. A. Agger,, J. R. Singer,, W. R. Yutuc,, K. L. Newcomer,, A. Schaper, et al. 1995 Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect. Control Hosp. Epidemiol. 16:506511.
24. Darouich, R. O.,, I. I. Raad,, S. O. Heard,, J. I. Thornby,, O. C. Wenker,, A. Garbrielli, et al. 1999. A comparison of two antimicrobial-impregnated central venous catheters. N. Engl. J. Med. 340:18.
25. Davies, D. G.,, M. R. Parsek,, J. P. Pearson,, B. H. Iglewski,, J. W. Costerton,, and E. P. Greenberg. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280: 295298.
26. DeMuri, G. P.,, and M. K. Hostetter. 1996. Evidence for a β1 integrin fibronectin receptor in Candida tropicalis. J. Infect. Dis. 174:127132.
27. Ena, J.,, E. Cercenado,, D. Martinez,, and E. Bouza. 1992. Cross-sectional epidemiology of phlebitis and catheter-related infections. Infect. Control Hosp. Epidemiol. 13:1520.
28. Flowers, R. H., III,, K. J. Schwenzer,, R. F. Kopel,, M. J. Fisch,, S. I. Tucker,, and B. M. Farr. 1989. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled nial. JAMA 261:878883.
29. Fridkin, S. K.,, S. M. Pear,, T. H. Williamson,, J. N. Galgiani,, and W. R. Jarvis. 1996. The role of understaffing in central venous catheter-associated bloodstream infections. Infect. Control Hosp. Epidemiol. 17:150158.
30. George, S. J.,, P. Vuddamalay,, and M. J. Boscoe. 1997. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur. J. Anaesthesiol. 14:428431.
31. Goetz, A. M.,, M. M. Wagener,, J. M. Miller,, and R. R. Muder. 1998. Risk of infection due to central venous catheters: effect of.site of placement and catheter type. Infect. Control Hosp. Epidemiol. 19:842845.
32. Goldschmidt, H.,, U. Hahn,, H. -,. I. Salwender,, R. Haas,, B. Jansen,, P. Wolbring, et al. 1995. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentbl. Bakteriol. 283:215223.
33. Groeger, J. S.,, A. B. Lucas,, D. Coit,, M. LaQuaglia,, A. E. Brown,, A. Turnbull, et al. 1993. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann. Surg. 218:206210.
34. Halpin, D. P.,, P. O'Byrne,, G. McEntee,. T. P. J. Hennessy,, and R. B. Stephens. 1991. Effect of a betadine connection shield on central venous catheter sepsis. Nutrition 7:3334.
35. Hannan, M.,, R. Juste,, U. Shankar,, C. Nightingale,, B. Axadian,, and N. Soni. 1996. Colonization of triple lumen catheters. A study on antiseptic bonded and standard catheters. Clin. Intensive Care 7:56.
36. Heard, S. O.,, M. Wagle,, E. Vijayakumar,, S. McLean,, A. Brueggemann,, L. M. Napolitano, et al. 1998. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadaizine on the incidence of catheter-related bacteremia. Arch. Intern. Med. 158:8187.
37. Hemmerlein, J. B.,, S. O. Treerotola,, M. A. Kraus,, M. S. Mencionen,, and L. A. Desmond. 1997. In vitro cytotoxicity of silver-impregnated collagen cuffs designed to decrease infection in tunneled catheters. Radiology 204:363367.
38. Herrmann, M.,, Q. J. Lai,, R. M. Albrecht,, D. F. Mosher,, and R. A. Proctor. 1993. Adhesion of Staphylococcus aureus to surface-bound platlets: role of fibrinogen/fibrin and platlet integrins. J. Infect. Dis. 167:312322.
39. Herrmann, M.,, S. J. Suchard,, L. A. Boxer,, F. A. Waldvogel,, and D. Lew. 1991. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect. Immun. 59: 279288.
40. Hiramatsu, K.,, N. Aritaka,, H. Hanaki,, S. Kawasaki,, Y. Hosoda,, S. Hori, et al. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:16701673.
41. Hoffmann, K. K.,, D. J. Weber,, G. P. Samsa,, and W. A. Rutala. 1992. Transparent polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA 267:20722076.
42. Inoue, Y.,, R. Nezu,, H. Matsutla,, M. Fujii,. S. Nakai,, M. Wasa, et al. 1992. Prevention of catheter-related sepsis during parenteral nutrition: effect of a new connection device. J. Patenter. Enteral. Nutr. 16:581585.
43. Jansen, B., 1997. Current approaches to the prevention of catheter-related infections, p. 411146. In H. Seifert,, B. Jansen,, and B. M. Farr (cd.), Catheter-Related Infections. Marcel Dekker, New York, N.Y..
44. King, T. C.,, and P. B. Price. 1963. An evaluation of iodophores as skin antiseptics. Surg. Gynecol. Obstet. 116:361365.
45. Kolter, R.,, and R. Losick. 1998. One for all and all for one. Science 280:226227.
46. Konner, K. 1995. Subclavian hacmodialysis access: is it still justified in 1995? Nephrol. Dial. Transplant. 10:19881991.
47. Lederle, F. A.,, C. Parenti,, L. Berskow,, and K. Ellingson. 1992. The idle intravenous catheter.. Ann. Intern. Med. 116:737738.
48. Levin, A.,, A. J. Mason,, K. K. Jindal,, I. W. Fong,, and M. B. Goldstein. 1991. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 40:934938.
49. Little, J. R.,, P. R. Murray,, P. S. Traynor,, and E. Spitznagel. 1999. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effect on rates of blood culture contamination. Am. J. Med. 107:119125.
50. Liu, W.-K. I.,, S. E. Tebbs,, P. O. Byrne,, and T. S. J. Elliott. 1993. The effects of electric current on bacteria colonising intravenous catheters. J. Infect. 27:261269.
51. Ljungman, P.,, H. Hagglund,, B. Lonnqvist,, and O. Ringden. 1997. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer 5:485488.
52. Logghe, C.,, C. Van Ossel,, W. D'Hoore,, H. Ezzedine,, G. Watiters,. and J. J. Haxhe. 1997. Evaluation of chlorhexidine and silver-stilfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukacmic patients: a randomized controlled trial. J. Hosp. Infect. 37:145156.
53. Maas, A.,, P. Flament,, A. Pardou,, A. Deplano,, M. Dramaix,, and M. J. Struelens. 1998. Central venous catheter-related bacteremia in critically ill neonates: risk factors and impact of a prevention programme. J. Hosp. Infect. 40:211224.
54. Maki, D. G.,, S. M. Stolz,, S. Wheeler,, and L. A. Mermel. 1997. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann. Intern. Med. 127:257266.
55. Maki, D. G.,, and J. D. Band. 1981. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am. J. Med. 70:739744.
56. Maki, D. G.,, L. Cobb,, J. K. Carman,, J. M. Shapiro,, M. Ringer,, R. B. Helgerson. 1988. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am. J. Med. 85:307314.
57. Maki, D. G.,, and L. Mermel. 1997. Meta-analysis of transparent vs. gauze dressings for central venous catheter use. Infect. Control Hosp. Epidemiol. 18(Suppl. 2):51.
58. Maki, D. G.,, and L. A. Mermel,. 1998. Infections due to infusion therapy, p. 689724. In J. Bennett, and P. Brachman (éd.), Hospital Infections, 4th ed. Lippencott-Raven, Philadelphia, Pa..
59. Maki, D. G.,, M. Ringer,, and C. J. Alvarado. 1991. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339343.
60. Maki, D. G.,, S. Stolz,, S. Wheeler,, and L. A. Mermel. 1994. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit. Care Med. 22:17291737.
61. McKee, R.,, R. Dunsmuir,, M. Whitby,, and O. J. Garden. 1985. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J. Hosp. Infect. 6:419425.
62. Mermel, L. A.,, R. D. McCormick,, S. R. Springman,, and D. G. Maki. 1991. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am. J. Med. 91:197S205S.
63. Mermel, L. A.,, S. M. Stolz,, and D. G. Maki. 1993. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J. Infect. Dis. 167:920924.
64. Mermel, L. A. 1998. Central venous catheter-related infections and their prevention: is there enough evidence to recommend tunneling for short-term use? Crit. Care Med. 26:13151316.
65. Mermel, L. A. 2000. Prevention of intravascular catheter-related infections. Ann. Intern. Med., 132: 391402.
66. Mimoz, O.,, L. Pieroni,, C. Lawrence,, A. Edouard,, Y. Costa,, K. Samii, et al. 1996. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit. Care Med. 24:18181823.
67. Nguyen, M. H.,, C. A. Kauflman,, R. P. Goodman,, C. Squier,, R. D. Arbeit,, N. Singh, et al. 1999. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann. Intern. Med. 130: 221225.
68. Nilsson, M.,, L. Frykberg,, J-. I. Flock,, L. Pei,, M. Lindberg,, and B. Guss. 1998. A fibrinogen-binding protein of Staphyloccus epidermidis. Infect. Immun. 66:26662673.
69. Parenti, C. M.,, F. A. Lederle,, C. L. Impola,, and L. R. Peterson. 1994. Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project. Arch. Intern. Med. 154:18291832.
70. Pearson, M. L., and the Hospital Infection Control Practices Advisory Committee. 1996. Guidelines for prevention of intravascular device-related infections. Infect. Control Hosp. Epidemiol. 17:438473.
71. Pemberton, L. B.,, V. Ross,, P. Cuddy,, H. Kremer,, T. Fessier,, and E. McGurk. 1996. No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized study. Arch. Surg. 131:986989.
72. Pinheiro, S. M. C.,, C. A. F. Starling,, and B. R. G. M. Couto. 1997. Transparent dressing versus conventional dressing: comparison of the incidence of related catheter infection. Am. J. Infect. Control 25:148.
73. Pittet, D. 1994. Nosocomial bloodstream infections in the critically ill. JAMA 272:18191820.
74. Raad, L.,, R. Hachem,, A. Zermeno,, L. C. Stephens,, and G. P. Bodey. 1996. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J. Infect. Dis. 173:495498.
75. Raad, I. I.,, W. Costerton,, U. Sabharwal,, M. Sacilowski,, E. Anaissie,, and G. P. Bodey. 1993. Ultrastructural analysis of indwelling vascular catheters. A quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis. 168:400407.
76. Raad, I. I.,, D. C. Hohn,, J. Gilbreath,, N. Suleiman,, L. A. Hill,, P. A. Bruso, et al. 1994. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect. Control Hosp. Epidemiol. 15:231238.
77. Raad, I. I.,, M. Luna,, S.-A. M. Khalil,, J. W. Costerton,, C. Lam,, and G. P. Bodey. 1994. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:10141016.
78. Ramsay, J.,, F. Nolte,, and S. Schwarzmann. 1994. Incidence of catheter colonization and catheter related infection with an antiseptic impregnated triple lumen catheter. Crit. Care Med. 22:A115.
79. Randolph, A. G.,, D. J. Cook,, C. A. Gonzales,, and M. Andrew. 1998. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled studies. Chest 113: 165171.
80. Randolph, A. G.,, D. J. Cook,, C. A. Gonzlaes,, and C. Brun-Buisson. 1998. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit. Care Med. 26:14521457.
81. Rao, S. P.,, and D. G. Oreopoulos. 1997. Unusual complications of a polyurethane PD catheter. Petit. Dial. Int. 17:410412.
82. Riu, S.,, C. G. Ruiz,, A. Martinez-Vera,, C. Peralta,, and J. A. Oliver. 1998. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol. Dial. Transplant. 13:18701871.
83. Robinson, J. F.,, W. A. Robinson,, A. Cohn,, K. Garg,, and J. D. Armstrong. 1995. Perforation of the great vessels during central venous line placement. Arch. Intern. Med. 155:12251228.
84. Ruschman, K. L.,, and J. S. Fulton. 1993. Effectiveness of disinfectant techniques on intravenous tubing latex injection ports, J. Intravenous Nurs. 16:304308.
85. Salzman, M. B.,, H. D. Isenberg,, and L. G. Rubin. 1993. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J. Clin. Microbiol. 31:475479.
86. Segura, M.,, F. Alvarez-Lerma,, J. Ma Tellado,, J. Jimenez-Ferreres,, L. Oms,, J. Relio, et al. 1996. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann. Surg. 223:363369.
87. Sesso, R.,, D. Barbosa,, I. L. Leme,, H. Sader,, M. E. Canziani,, S. Manfredi, et al. 1998. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J. Am. Soc. Nephrol. 9:10851092.
87a.. Sherertz, R. J.,, E. W. Ely,, D. M. Westbrook,, K. S. Gledhill,, S. A. Streed,, B. Kiger,, L. Flynn,, S. Hayes,, S. Strong,, J. Cruz,, D. L. Bowton,, T. Hulgan,, and E. F. Haponik. 2000. Education of physicians-in-training can decrease the risk of vascular catheter infection. Ann. Intern. Med. 132:641648.
88. Sierakzki, K.,, R. B. Roberts,, S. W. Haber,, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340: 517523.
89. Sierdazki, K.,, R. B. Roberts,, D. Serur,, J. Hargrave,, and A. Tomaz. 1998. Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin. Lancet 351:880885.
90. Smith, T.,, M. L. Pearson,, K. R. Wilcox,, C. Cruz,, M. V. Lancaster,, B. Robinson-Dunn, et al. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340:493501.
91. Soifer, N. E.,, S. Borzak,, B. R. Edlin,, and R. A. Weinstein. 1998. Prevention of peripheral venous catheter complications with an intravenous therapy team. A randomized controlled study. Arch. Intern. Med. 158: 473477.
92. Spafford, P. S.,, R. A. Sinkin,, C. Cox,, L. Reubens,, and K. R. Powell. 1994. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J. Pediatr. 125:259263.
93. Strand. C. L.,, R. R. Wajsbort,, and K. Sturmann. 1993. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA 269:10041006.
94. Sun, Q.,, G. M. Smith,, C. Zahradka,, and M. J. McGavin. 1997. Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of ftbronectin binding. Infect. Immun. 65:537543.
95. Tabone, E.,, J. F. Latour,, A. Mignot,, and J. Y. Ranchere. 1991. Alteration of the inner surface of venous catheters by antineoplastic drugs. Biomaterials 12:741746.
96. Tattawasart, U.,, J.-Y. Maillard,. J. R. Furr,, and A. D. Russell. 1999. Development of resistance to chlorhexidine diacetate and cetylpyridimium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J. Hosp. Infect. 42:219229.
97. Timsit, J.-F.,, F. Bruneel,, C. Dhcheval,, M.-F. Mamzer,, M. Garrouster-Orgeas,, M. Wolff, et al. 1999. Subcutaneous tunneling is effective in preventing femoral catheter-related sepsis in intensive care unit patients. A prospective randomized multicenter study. Ann. Intern. Med. 130:729735.
98. Timsit, J.-F.,, J.-C. Farkas,, J.-M. Boyer,, J.-B. Martin,, B. Misset,, B. Renaud, et al. 1998. Central vein catheter-related thrombosis in intensive care patients. Incidence, risk factors, and relationship with catheter-related sepsis. Chest 114:207213.
99. Timsit, J.-F.,, V. Sebille,, J.-C. Farkas,, B. Misset,, J.-B. Martin,, S. Chevret, et al. 1996. Effect of subcutaneous tinneling on internal jugular catheter-related sepsis in critically ill patients. A prospective randomized multicenter study. JAMA 276:14161420.
100. Toshiyuki, O.,, H. Junichiro,, K. Naomi,, and K. Mikami. 1997. Anaphylactic shock induced by an antiseptic-coated central nervous catheter. Anesthesiology 87:12421244.
101. Trottier, S. J.,, C. Veremakis,, J. O'Brien,, and A. A. Auer. 1995. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit. Care Med. 23:5259.
102. van Heerden, P. V.,, S. A. R. Webb,, S. Fong,, C. L. Golledges,, B. L. Roberts,, and W. R. Thompson. 1996. Central venous catheters revisited—infection rates and an assessment of the new fibrin analysing system brush. Anaesth. Intens. Care 24:330333.
103. Veenstra, D. L.,, S. Saint,, S. Saha,, T. Lumley, andS. D. Sullivan. 1999. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A Meta-analysis. JAMA 281: 261267.
104. Veenstra, D. L.,, S. Saint,, and S. D. Sullivan. 1999. Cost-effectiveness of antiseptic-impregnated central venous catheters for prevention of catheter-related bloodstream infection. JAMA 282:554560.
105. Viale, P.,, E. Politi,, M. Sisti,, M. Confalonieri,, and F. Alberici. 1998. Impact of central venous catheters (CVC) management on infectious risk. J. Hosp. Infect. 40(Suppl. A):8.1.8.
106. Weist, K.,, A. Sperber,, E. Dietz,, and H. Ruden. 1997. Contamination of stopcocks mounted in administration sets for central venous catheters with replacement at 24 hrs versus 72 hrs: a prospective cohort study. Infect. Control Hosp. Epidemiol. 18(5, part 2):24.
107. Willie, J. C.,, A. Blusse van Oud Alblas,, and E. A. P. M. Thewessen. 1993. A comparison of two transparent film-type dressings in central venous therapy. J. Hosp. Infect. 23:113121.
108. Zakrzewska-Bode, A.,, H. L. Muytjens,, K. D. Liem,. and J. A. A. Hoogkamp-Korstanje. 1995. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J. Hosp. Infect. 31:189193.
109. Ziebuhr, W.,, C. Heilmann,, F. Gotz,, P. Meyer,, K. Wilms,, E. Straube, et al. 1997. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 6S:890896.

Tables

Generic image for table
Table 1

Efficacy of systemic antimicrobial prophylaxis during central venous catheter insertion in prevention of catheter-related infections

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20
Generic image for table
Table 2

The efficacy of chlorhexidine-containing cutaneous antiseptics in the prevention of central venous, pulmonary artery, and peripheral arterial catheter-related infections

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20
Generic image for table
Table 3

Risk of central venous, pulmonary artery, and peripheral arterial catheter infection with use of gauze and transparent dressings

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20
Generic image for table
Table 4

Efficacy of the chlorhexidine-silver sulfadiazine-impregnatcd central venous catheters in the prevention of catheter-related infections

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20
Generic image for table
Table 5

Recommendations for the prevention of intravascular catheter-related infections

Citation: Mermel L. 2000. Preventive Strategies for Intravascular Catheter-Related Infections, p 407-425. In Waldvogel F, Bisno A (ed), Infections Associated with Indwelling Medical Devices, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818067.ch20

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error